NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 918 filers reported holding NOVARTIS A G in Q3 2015. The put-call ratio across all filers is 1.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $46,603,000 | -20.6% | 639,795 | -13.9% | 0.89% | -17.2% |
| Q3 2016 | $58,703,000 | -12.8% | 743,447 | -8.8% | 1.08% | -10.6% |
| Q2 2016 | $67,296,000 | +9.4% | 815,609 | -4.0% | 1.21% | +5.9% |
| Q1 2016 | $61,534,000 | -19.4% | 849,451 | -4.3% | 1.14% | -16.8% |
| Q4 2015 | $76,353,000 | -13.7% | 887,414 | -7.8% | 1.37% | -6.6% |
| Q3 2015 | $88,519,000 | -9.3% | 962,995 | -2.9% | 1.46% | +11.5% |
| Q2 2015 | $97,547,000 | +19.0% | 991,932 | +19.3% | 1.31% | +6.1% |
| Q1 2015 | $81,994,000 | +8.7% | 831,494 | +2.2% | 1.24% | +6.8% |
| Q4 2014 | $75,409,000 | +11.2% | 813,827 | +13.0% | 1.16% | +10.5% |
| Q3 2014 | $67,809,000 | +5.4% | 720,373 | +1.4% | 1.05% | +3.0% |
| Q2 2014 | $64,327,000 | +8.4% | 710,570 | +1.8% | 1.02% | -6.3% |
| Q1 2014 | $59,336,000 | – | 697,913 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |